Whereas DNAH8 mRNA expression was significantly increased in primary tumors compared with normal prostate (p = 0.0049), and was further up-regulated in metastatic tumors (p < 0.0001, Figure 2C), DNAH5 expression did not significantly differ among normal prostate, primary or metastatic prostate tumors (p = 0.78, Figure 2D). The gene discussed is DNAH5; the disease is metastatic neoplasm.